Background/Aims: Blood-retinal barrier (BRB) breakdown and vascular leakage is the
leading cause of blindness of diabetic retinopathy (DR). Hyperglycemia-induced oxidative …

Purpose To assess the effectiveness and safety of intravitreal aflibercept in clinically
significant diabetic macular edema (DME) in daily clinical practice. Methods Prospective …

Purpose: To determine whether baseline cytokine aqueous humor (AH) levels are
associated with diabetic macular edema (DME) anatomic response to dexamethasone …

Highlights•Current treatment for diabetic retinopathy targets late stages of the
disease.•Promising novel drug candidates include integrin antagonists and Tie-2 …

Diabetic macular edema (DME) is caused by blood-retinal barrier breakdown associated
with retinal vascular hyperpermeability and inflammation, and it is the major cause of visual …

We examined the association between bioimpedance profiles and optical coherence
tomography (OCT) features in patients with diabetic macular edema (DME). This cross …

Background: Intravitreal anti-vascular endothelial growth factor (anti-VEGF) and steroid
treatment are both used for macular edema (ME) secondary to retinal vein occlusion (RVO) …

Ethnopharmacological relevance According to ancient traditional Chinese medicine, Typhae
Pollen (TP) is commonly used to treat fundus haemorrhage because it improves blood …

The current study aimed to address whether ripasudil, a Rho-associated coiled-coil
containing protein kinase (ROCK) inhibitor developed to treat glaucoma and ocular …

Background This was an updated network meta-analysis (NMA) of anti-vascular endothelial
growth factor (VEGF) agents and laser photocoagulation in patients with diabetic macular …